In a letter addressed to its partners, the once-promising blood test startup Theranos has admitted that it’s under criminal investigation. According to multiple sources, the US Securities and Exchange Commission and the US Attorney’s Office for the Northern District of California have started looking into whether the firm misled its investors about the state of its technology.